Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.

Journal of medical virology - 1 Jan 2004

Kuwahara Reiichiro, Kumashiro Ryukichi, Murashima Shiro, Ogata Kei, Tanaka Kazuo, Hisamochi Akiko, Hino Teruko, Ide Tatsuya, Tanaka Eisuke, Koga Yuriko, Sata Michio

Abstract excerpt

It has been reported that spontaneous or interferon (IFN)-induced hepatitis B e (HBe) seroconversion has usually been associated with the development of a stop codon in the precore region. However, the difference between lamivudine-induced seroconversion and spontaneous or IFN-induced seroconvers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Core Antigens

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Lamivudine

Share to Protein Precursors

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 14635007
DOI: 10.1002/jmv.10558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14635007-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.PMID 14635007Read ↗

Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.Semantic proximity Read ↗

Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.Semantic proximity Read ↗

Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.Semantic proximity Read ↗

HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.Semantic proximity Read ↗

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Semantic proximity Read ↗

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.Semantic proximity Read ↗

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy.Semantic proximity Read ↗

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.Semantic proximity Read ↗

Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy.Semantic proximity Read ↗

Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy.Semantic proximity Read ↗

Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.Semantic proximity Read ↗

Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.